EXCELLENT POST!!!
Great read on the EPIC applications of modulating our Check Point NR2F6!
And just think, this is only (1) in our "inventory" of Bio-Pharmaceutical Market application Patents, any one of which has a Muti-Billion Dollar Market Capacity!
This is the very kind of thing Big Pharmas open their WALLETS WIDE to snap up before their competitors get hold of it!...and by Koos re-activating all or most of our Patents, puts US INSTANTLY back on "Big Pharma" radar!
It's all about advancing innovative biotechnology that's continuously evolving and what we have are KEY TURNING POINTS to a variety of life changing Immuno-therapy applications that have the capacity to significantly lessen the impact of disease morbidity.
IMO, we're entering the Age of Bio-Pharmaceutical advancements that will substantially reduce chronic diseases to "near cure" levels because of BioPharmas like RGBP with ground breaking Patents that will come to Market at warp speed.
So now we, RGBP, are definitely viewed as a "GO TO" Advanced Biotechnology Incubator for such advancements to become a Market reality and Big Pharmas that have the financial power and infrastructure to make it happen know this and no doubt we are on their Radar, and everyone here can best believe that!
Continuous surveillance of breaking new Patent Technologies that can impact their bottom line is a TOP PRIORITY of ALL Big Pharmas, and that goes without saying.
They ALL have a dedicated team that does nothing but this in order to stay ahead of their competitors which is also the reason why we saw Gilead willing to shell out $12 Billion for Kite Pharma's single Patent like it was "chump change!" Heck Gilead even paid them several multiples on their PPS to boot and yet they had FAR LESS than what RGBP has...in fact no comparison!
Hold on to our hats....BIG THINGS ABOUT TO HAPPEN!!!
Be well and prosper...
